These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Proceedings: Electrophysiological study of a case of Jacob-Creutzfeldt disease. Capon A; Colin F; Flament-Durand J Electroencephalogr Clin Neurophysiol; 1975 Nov; 39(5):533. PubMed ID: 52457 [No Abstract] [Full Text] [Related]
6. [Creutzfeldt-Jacob disease. A case report]. Moland L Tidsskr Nor Laegeforen; 1996 Mar; 116(8):981-2. PubMed ID: 8650662 [TBL] [Abstract][Full Text] [Related]
7. Psychopathology of dementia: implications for neuropathology. McHugh PR; Folstein MF Res Publ Assoc Res Nerv Ment Dis; 1979; 57():17-30. PubMed ID: 368926 [No Abstract] [Full Text] [Related]
8. [Creutzfeldt-Jakob disease and psychiatry. Apropos of a case]. Alezrah C; Monteil AL; Faillie X; Hatem O Encephale; 1997; 23(1):72-5. PubMed ID: 9172971 [TBL] [Abstract][Full Text] [Related]
9. [Absence of periodic discharges in a patient with Creutzfeldt-Jacob disease]. Sadeh M; Goldhammer Y Harefuah; 1982 Nov; 103(10):259-60. PubMed ID: 6763592 [No Abstract] [Full Text] [Related]
11. The EEG and clinical evolution in Creutzfeldt-Jacob disease. Erkulwater S Clin Electroencephalogr; 1987 Oct; 18(4):211-7. PubMed ID: 3311476 [TBL] [Abstract][Full Text] [Related]
12. [Contribution to the electro-clinical study of the effect of diazepam in Creutzfeldt-Jakob disease]. Gaches J; Supino-Viterbo V; Oughourlian JM Sem Hop; 1972 May; 48(22):1601-6. PubMed ID: 4340959 [No Abstract] [Full Text] [Related]
13. [Pharmacokinetic studies following oral application of amitriptyline and chlorazaptate in therapeutic dosage]. Sticht G; Kăferstein H; Staak M; Langenberg K Beitr Gerichtl Med; 1983; 41():109-15. PubMed ID: 6139107 [No Abstract] [Full Text] [Related]
14. [Amantadine in Creutzfeldt-Jakob disease. Review of the literature and case contribution]. Neri G; Figà-Talamanca L; Di Battista GC; Lo Russo F Riv Neurobiol; 1984; 30(1):47-56. PubMed ID: 6399949 [No Abstract] [Full Text] [Related]
15. How heterogeneous can the clinical presentation for Creutzfeldt-Jacob disease be? Sobreira S; Mota IA; Gomes da Cunha JE; Mello R; Oliveira JR J Neuropsychiatry Clin Neurosci; 2013; 25(4):E44-5. PubMed ID: 24247888 [No Abstract] [Full Text] [Related]
16. Depressive disorder with psychotic symptoms as psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a case report. Jardri R; DiPaola C; Lajugie C; Thomas P; Goeb JL Gen Hosp Psychiatry; 2006; 28(5):452-4. PubMed ID: 16950387 [TBL] [Abstract][Full Text] [Related]
17. [Apropos of a case of Creutzfeldt-Jakob disease in a pseudo-tumoral form]. Pechadre JC; Drolet MN; Bélanger C Union Med Can; 1974 Jan; 103(1):93-8. PubMed ID: 4590297 [No Abstract] [Full Text] [Related]
18. [The chlorazepate test in anxiety-depressive states]. Peyre F; Bourgeois M Ann Med Psychol (Paris); 1988; 146(7):655-62. PubMed ID: 2906229 [No Abstract] [Full Text] [Related]
19. [Temporal profile of mental symptoms in Creutzfeldt-Jakob syndrome (author's transl)]. Suetsugu M; Moriyama N; Mitsuyama Y; Yamada M; Takamatsu I No To Shinkei; 1982 Feb; 34(2):159-64. PubMed ID: 7044394 [No Abstract] [Full Text] [Related]
20. [Creutzfeldt-Jakob syndrome in the county of Storstrom during the period 1990-1999. Was there a significant accumulation of cases?]. Christoffersen BR; Jansen J Ugeskr Laeger; 2001 Nov; 163(45):6275-9. PubMed ID: 11723687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]